During the past decade, CHAPEL ALLERTON HOSPITAL; Unit of Musculoskeletal Disease conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CHAPEL ALLERTON HOSPITAL; Unit of Musculoskeletal Disease" are "Giant Cell Arteritis" (1 trials) and "Lupus Nephritis" (1 trials). Many other conditions were trialed in "CHAPEL ALLERTON HOSPITAL; Unit of Musculoskeletal Disease" in a lesser frequency.

Most popular intervention types in "CHAPEL ALLERTON HOSPITAL; Unit of Musculoskeletal Disease" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Prednisone" (2 trials), "Acetaminophen" (1 trials), "Corticosteroids" (1 trials), "Diphenhydramine" (1 trials) and "MMF" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHAPEL ALLERTON HOSPITAL; Unit of Musculoskeletal Disease" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CHAPEL ALLERTON HOSPITAL; Unit of Musculoskeletal Disease". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CHAPEL ALLERTON HOSPITAL; Unit of Musculoskeletal Disease, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHAPEL ALLERTON HOSPITAL; Unit of Musculoskeletal Disease, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".